In lung cancer, PRKCSH controls cell adhesion molecules (CAMs), which are essential for T-cell surveillance [9],], stabilizes the insulin-like growth factor 1 receptor (IGF1R), and increases resistance to tumor necrosis factor superfamily (TNFSF)-induced apoptosis [15]. This evidence concerns the gene IGF1R and lung cancer.